Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 12.45% |
| 4 | Miscellaneous | 11.59% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Organon & Co
OGN
$3.61B
| $4M | ﹤0.01% |
170,870
+29,261
| +21% | +$883K |
|
|
DNB
1277
DELISTED
Dun & Bradstreet
DNB
| $3.99M | ﹤0.01% |
322,251
+291,032
| +932% | +$4.32M |
|
|
EIGR
1278
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.97M | ﹤0.01% |
17,559
-10
| -0.1% | -$2.46K |
|
1279
Borealis Foods
BRLS
$29.8M
| $3.96M | ﹤0.01% |
391,200
| – | – |
|
1280
SoFi Technologies
SOFI
$21.4B
| $3.95M | ﹤0.01% |
810,017
-1,134,529
| -58% | -$7.18M |
|
|
CTIC
1281
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.95M | ﹤0.01% |
678,613
+673,949
| +14,450% | +$4.2M |
|
1282
Ormat Technologies
ORA
$5.76B
| $3.94M | ﹤0.01% |
45,725
-833,703
| -95% | -$74.2M |
|
|
USCT
1283
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
| $3.93M | ﹤0.01% |
387,948
| – | – |
|
1284
Telefônica Brasil
VIV
$18.5B
| $3.93M | ﹤0.01% |
522,498
+98
| +0% | +$829 |
|
1285
Curtiss-Wright
CW
$19.9B
| $3.93M | ﹤0.01% |
28,217
-5,144
| -15% | -$730K |
|
1286
iShares Core S&P 500 ETF
IVV
$848B
| $3.93M | ﹤0.01% |
10,952
-7,754
| -41% | -$3.1M |
|
1287
PUT
Xerox
XRX
$436M
| $3.92M | ﹤0.01% |
+300,000
| New | +$4.86M |
|
1288
Erie Indemnity
ERIE
$11.7B
| $3.92M | ﹤0.01% |
17,646
-1,038
| -6% | -$219K |
|
|
VERV
1289
DELISTED
Verve Therapeutics
VERV
| $3.9M | ﹤0.01% |
113,671
+108,815
| +2,241% | +$3.47M |
|
1290
PUT
Applovin
APP
$104B
| $3.9M | ﹤0.01% |
200,000
| – | – |
|
1291
ManpowerGroup
MAN
$2.67B
| $3.9M | ﹤0.01% |
60,269
-10,435
| -15% | -$785K |
|
|
TERN
1292
DELISTED
Terns Pharmaceuticals
TERN
| $3.88M | ﹤0.01% |
659,098
+645,973
| +4,922% | +$2.4M |
|
1293
Brookfield Renewable
BEPC
$5.29B
| $3.88M | ﹤0.01% |
118,688
+25,036
| +27% | +$963K |
|
|
AAIC
1294
DELISTED
Arlington Asset Investment Corp.
AAIC
| $3.87M | ﹤0.01% |
1,421,438
-40,651
| -3% | -$128K |
|
|
BBBY
1295
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.87M | ﹤0.01% |
634,555
+550,415
| +654% | +$4.48M |
|
1296
Telus
TU
$13.4B
| $3.86M | ﹤0.01% |
194,483
+36,291
| +23% | +$810K |
|
1297
PUT
Accenture
ACN
$108B
| $3.86M | ﹤0.01% |
+15,000
| New | +$4.33M |
|
1298
Park Hotels & Resorts
PK
$3.11B
| $3.85M | ﹤0.01% |
341,970
+58,797
| +21% | +$837K |
|
1299
Twist Bioscience
TWST
$12.1B
| $3.85M | ﹤0.01% |
109,173
+94,574
| +648% | +$4.02M |
|
|
WCC
1300
WESCO International
WCC
$17.9B
| $3.83M | ﹤0.01% |
32,078
+6,766
| +27% | +$847K |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays deployed $5.45B of net new capital in Q3 2022, opening 261 new positions and adding to 1,854 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $873M trimmed.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.